Titre : Polyangéite microscopique

Polyangéite microscopique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prevalence
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Polyangéite microscopique : Questions médicales les plus fréquentes", "headline": "Polyangéite microscopique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Polyangéite microscopique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-03", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Polyangéite microscopique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "url": "https://questionsmedicales.fr/mesh/D056648", "about": { "@type": "MedicalCondition", "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "code": { "@type": "MedicalCode", "code": "D056648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111.193" } } }, "about": { "@type": "MedicalCondition", "name": "Polyangéite microscopique", "alternateName": "Microscopic Polyangiitis", "code": { "@type": "MedicalCode", "code": "D055953", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jason Jungsik Song", "url": "https://questionsmedicales.fr/author/Jason%20Jungsik%20Song", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea." } }, { "@type": "Person", "name": "Sang-Won Lee", "url": "https://questionsmedicales.fr/author/Sang-Won%20Lee", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea. sangwonlee@yuhs.ac." } }, { "@type": "Person", "name": "Sung Soo Ahn", "url": "https://questionsmedicales.fr/author/Sung%20Soo%20Ahn", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea." } }, { "@type": "Person", "name": "Yong-Beom Park", "url": "https://questionsmedicales.fr/author/Yong-Beom%20Park", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, and Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea." } }, { "@type": "Person", "name": "Taejun Yoon", "url": "https://questionsmedicales.fr/author/Taejun%20Yoon", "affiliation": { "@type": "Organization", "name": "Department of Medical Science, College of Medicine, BK21 Plus Project, Yonsei University, Seoul, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prevalence of", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37096666", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S095026882200187X" } }, { "@type": "ScholarlyArticle", "name": "The Prevalence of", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/36518926", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4055/cios20068" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36004681", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13816810.2022.2109686" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of", "datePublished": "2023-09-05", "url": "https://questionsmedicales.fr/article/37668557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/19396368.2023.2247517" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36759179", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/sextrans-2022-055687" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Vascularites associées aux anticorps anti-cytoplasme des neutrophiles", "item": "https://questionsmedicales.fr/mesh/D056648" }, { "@type": "ListItem", "position": 5, "name": "Polyangéite microscopique", "item": "https://questionsmedicales.fr/mesh/D055953" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Polyangéite microscopique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Polyangéite microscopique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Polyangéite microscopique", "description": "Comment diagnostiquer la polyangéite microscopique ?\nQuels tests sanguins sont utilisés ?\nQuels symptômes orientent vers ce diagnostic ?\nLa biopsie est-elle toujours nécessaire ?\nQuels examens d'imagerie sont recommandés ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Polyangéite microscopique", "description": "Quels sont les symptômes courants ?\nLa polyangéite microscopique cause-t-elle des problèmes rénaux ?\nY a-t-il des symptômes respiratoires associés ?\nLes symptômes varient-ils d'un patient à l'autre ?\nPeut-on avoir des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Polyangéite microscopique", "description": "Peut-on prévenir la polyangéite microscopique ?\nQuels conseils de mode de vie peuvent aider ?\nLes vaccinations sont-elles recommandées ?\nFaut-il éviter certains médicaments ?\nLe suivi médical est-il important ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Polyangéite microscopique", "description": "Quels traitements sont utilisés pour cette maladie ?\nLes corticostéroïdes sont-ils efficaces ?\nCombien de temps dure le traitement ?\nY a-t-il des effets secondaires aux traitements ?\nDes traitements biologiques sont-ils disponibles ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Polyangéite microscopique", "description": "Quelles sont les complications possibles ?\nLa polyangéite microscopique peut-elle être mortelle ?\nComment prévenir les complications ?\nLes complications affectent-elles la qualité de vie ?\nY a-t-il des complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Polyangéite microscopique", "description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes infections peuvent-elles déclencher la maladie ?\nLe sexe joue-t-il un rôle dans le risque ?\nDes facteurs environnementaux sont-ils impliqués ?", "url": "https://questionsmedicales.fr/mesh/D055953?mesh_terms=Prevalence&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la polyangéite microscopique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des analyses sanguines, des biopsies et des examens d'imagerie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la recherche d'anticorps anti-MPO et des marqueurs d'inflammation." } }, { "@type": "Question", "name": "Quels symptômes orientent vers ce diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes comme la fatigue, la fièvre, et des douleurs articulaires peuvent indiquer la maladie." } }, { "@type": "Question", "name": "La biopsie est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, la biopsie n'est pas toujours nécessaire, mais elle peut confirmer le diagnostic." } }, { "@type": "Question", "name": "Quels examens d'imagerie sont recommandés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les IRM et les scanners peuvent aider à visualiser les atteintes organiques." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, fièvre, éruptions cutanées et douleurs musculaires." } }, { "@type": "Question", "name": "La polyangéite microscopique cause-t-elle des problèmes rénaux ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner une insuffisance rénale aiguë due à l'inflammation des vaisseaux rénaux." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la toux et des douleurs thoraciques peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'un patient à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent varier considérablement." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des maux de tête ou des troubles de la vision peuvent apparaître." } }, { "@type": "Question", "name": "Peut-on prévenir la polyangéite microscopique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé." } }, { "@type": "Question", "name": "Quels conseils de mode de vie peuvent aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, éviter le tabac et gérer le stress peuvent être bénéfiques." } }, { "@type": "Question", "name": "Les vaccinations sont-elles recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir certaines infections, surtout sous traitement immunosuppresseur." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent aggraver la maladie, il est donc important de consulter un médecin." } }, { "@type": "Question", "name": "Le suivi médical est-il important ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier permet de surveiller l'évolution de la maladie et d'ajuster le traitement." } }, { "@type": "Question", "name": "Quels traitements sont utilisés pour cette maladie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent efficaces pour contrôler l'inflammation et soulager les symptômes." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie, mais peut durer plusieurs mois à plusieurs années." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les effets secondaires peuvent inclure des infections, des troubles digestifs et des problèmes osseux." } }, { "@type": "Question", "name": "Des traitements biologiques sont-ils disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements biologiques comme le rituximab peuvent être utilisés dans certains cas." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance rénale, les infections et les problèmes pulmonaires." } }, { "@type": "Question", "name": "La polyangéite microscopique peut-elle être mortelle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement approprié, elle peut entraîner des complications graves et potentiellement mortelles." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et un suivi régulier sont essentiels pour prévenir les complications." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Y a-t-il des complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications à long terme peuvent inclure des problèmes rénaux chroniques et des troubles pulmonaires." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, le tabagisme et certaines infections." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la polyangéite microscopique est plus fréquente chez les adultes âgés de 50 à 70 ans." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher la maladie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales ou bactériennes peuvent être des déclencheurs." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la maladie est légèrement plus fréquente chez les hommes que chez les femmes." } }, { "@type": "Question", "name": "Des facteurs environnementaux sont-ils impliqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certains produits chimiques ou médicaments peut augmenter le risque." } } ] } ] }

Sources (10000 au total)

The Prevalence of

This study aimed to investigate the prevalence of... This retrospective nationwide study identified subjects from the Korean National Health Insurance Service-Senior cohort. The subjects of this study were patients who were over 65 years old and underwe... The prevalence of CDC during the hospitalization period in the elderly patients with hip fractures was 1.43%. Compared to the non-CDC group, the CDC group had a 2.57-fold risk of 30-day mortality afte... The prevalence of CDC after hip fracture surgery in elderly patients was 1.43%. CDC after hip fracture in the elderly patients significantly increased the all-cause mortality rate after discharge....

Prevalence of

X-linked retinitis pigmentosa (XLRP) is a rare inherited retinal disease predominantly affecting males.... A comprehensive literature review was conducted to determine the prevalence of retinitis pigmentosa GTPase regulator... The prevalence of XLRP was estimated to be between 2.7-3.5 per 100,000 males in the US, Europe, and Australia. After correction for misclassification, the prevalence increased to 4.0-5.2 per 100,000 m... These findings address an important gap in the understanding of...

Prevalence of

To summarise the prevalence of... We searched MEDLINE, Embase, Web of Science and Global Index Medicus up to 30 September 2022. We included studies reporting the prevalence of MG and/or antibiotic-resistant MG infection among PrEP use... A total of 15 studies were included in the systematic review, with 2341 individuals taking PrEP. Studies were conducted in high-income level countries between 2014 and 2019. Median age of participants... We observed a high prevalence of MG and its macrolide resistance among PrEP users, highlighting the need to reinforce prevention strategies against sexually transmitted infections in this population.... CRD42022310597....

Changes in prevalence of

Macrolide and fluoroquinolone resistance in... MG-positive samples from 2006 to 2018 from patients examined at the Department of Venereology, Central Hospital, Falun, Sweden were tested by sequencing for macrolide resistance mutations (MRM) and fl... Of 874 samples, 98 (11.2%, 95% CI 9.1% to 13.6%) had mutations associated with resistance to macrolides and 19 of 828 (2.3%, 95% CI 8.9% to 23.1%) to quinolones. Mutations associated with resistance t... Despite a decrease in macrolide and fluoroquinolone consumption in Sweden, there was an overall increase in MG macrolide, fluoroquinolone and dual resistance from 2006 to 2018, although the difference...

Prevalence and trends of

A systematic review and meta-analysis of studies reporting rates of CDI among persons requiring MHD in MEDLINE, Embase, Web of Science Core Collection, CINAHL, and Cochrane Central Register of Control... In total, 2,408 titles and abstracts were identified; 240 underwent full text review. Among them, 15 studies provided data on rates of CDI among persons requiring MHD, and 8 of these also provided rat... Persons requiring MHD have a 4-fold higher risk of CDI compared to persons not requiring MHD, and rates of CDI are increasing over time in both groups....

Prevalence and predictors of

Although a high... Healthy subjects who underwent hospital health examinations in the hospital health management department from September 2020 to September 2021 were consecutively enrolled. Anthropometric and biochemic... Of the 5007 participants included, the overall prevalence of... These findings suggest that detailed and strict weight and glucose management is crucial to reduce the prevalence of H. pylori infection. Management strategies should be identified and implemented wit...